The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of cabozantinib plus nivolumab (CaboNivo) and cabonivo plus ipilimumab (CaboNivoIpi) in patients (pts) with refractory metastatic (m) urothelial carcinoma (UC) and other genitourinary (GU) tumors.
 
Andrea B. Apolo
No Relationships to Disclose
 
Amir Mortazavi
Consulting or Advisory Role - Genentech/Roche
 
Mark N. Stein
Research Funding - Abbvie (Inst); Advaxis (Inst); Astellas Pharma (Inst); Bavarian Nordic (Inst); Janssen Oncology (Inst); Medivation/Astellas (Inst); Merck Sharp & Dohme (Inst); Oncoceutics (Inst)
 
Nicole N. Davarpanah
No Relationships to Disclose
 
Rosa Maria Nadal
No Relationships to Disclose
 
Howard L. Parnes
No Relationships to Disclose
 
Yangmin M. Ning
No Relationships to Disclose
 
Deneise C Francis
No Relationships to Disclose
 
Lisa M Cordes
No Relationships to Disclose
 
Marilise Anne Berniger
No Relationships to Disclose
 
Seth M. Steinberg
No Relationships to Disclose
 
Piyush K. Agarwal
No Relationships to Disclose
 
Mohammadhadi H. Bagheri
No Relationships to Disclose
 
Swati Nanda
No Relationships to Disclose
 
Paul Monk
Consulting or Advisory Role - Bayer; Lilly
Speakers' Bureau - Dendreon; Sanofi
Research Funding - Prometheus
Travel, Accommodations, Expenses - Lilly
 
Tiffany Lancaster
No Relationships to Disclose
 
Tina Moore
No Relationships to Disclose
 
Rene Costello
No Relationships to Disclose
 
Donald P. Bottaro
No Relationships to Disclose
 
Sumanta K. Pal
Honoraria - Astellas Pharma; Medivation; Novartis
Consulting or Advisory Role - Astellas Pharma; Aveo; Bristol-Myers Squibb; Exelixis; Genentech; Myriad Pharmaceuticals; Novartis; Pfizer
Research Funding - Medivation